Citizens Reiterates Market Outperform Rating on Lyell Immunopharma (LYEL)

March 16, 2026 5:02 AM

Citizens analyst Reni Benjamin reiterated a Market Outperform rating and $34.00 price target on Lyell Immunopharma (NASDAQ: LYEL).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found